Progyny Q4 rev $298.4M (+10.6%); large client non-renewal pressures 2025 guide of 1-5% growth

Progyny, Inc.

2024-FY EPS reported $0.57 revenue$1,167,221,000

Q4 revenue $298.4M (+10.6% YoY); net income $10.5M ($0.12 diluted EPS) vs $13.5M ($0.13) prior year.
Adjusted Q4 EPS $0.42 vs $0.32 prior year; Adjusted EBITDA $47.5M (+10%).
Full year 2024 revenue $1,167.2M (+7.2%); net income $54.3M ($0.57) vs $62.0M ($0.62).
One large client did not renew for 2025; excluding it, 2024 revenue grew 8.5%; expects >530 clients in 2025.
FY2025 guidance: revenue $1.175B-$1.225B (1-5% growth), adjusted EBITDA $188M-$201M, adjusted EPS $1.52-$1.62.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.